Besides, Atractylenolide can affect PDK1/FoxO1, AKT/mTOR, and JAK/STAT3 pathways, inhibiting cancer cells’ proliferation, migration, and invasive ability (Li et al., 2020; Wang K et al., 2020; Sun et al., 2022). The gene discussed is AKT1; the disease is cancer.